Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
NightHawk Biosciences is a fully integrated biopharmaceutical company focused on the development of new drugs from discovery through commercialization. The Company leverages its integrated ecosystem of subsidiaries to accelerate the creation and manufacture of novel therapies that arm the immune system, breaking through barriers that prolong traditional drug development. This empowers us to bring our ideas to life with efficient control, superior quality, and uncharacteristic agility.
| Last: | $0.068 |
|---|---|
| Change Percent: | 2.27% |
| Open: | $0.129 |
| Close: | $0.068 |
| High: | $0.133 |
| Low: | $0.057949 |
| Volume: | 1,313,189 |
| Last Trade Date Time: | 04/21/2025 10:59:26 am |
| Market Cap: | $55,028 |
|---|---|
| Float: | 240,686 |
| Insiders Ownership: | 2.53% |
| Institutions: | 5 |
| Short Percent: | 162618% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.nighthawkbio.com |
| Country: | US |
| City: | San Antonio |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Scorpius Holdings Inc. (NYSE: SCPX).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.